| Acquired Immune Response |
| Ankylosing spondylitis |
| Anti-Beta-2-Glycoprotein Antibody |
| Anti-DNA Antibody |
| Anticardiolipin Antib. |
| Antiphospholipid Antibody Syndrome |
| Antithrombin Deficiency |
| Autoimmune Lymphoproliferative Syndrome (ALPS) |
| B Lymphocyte Deficiency |
| C3 (immune) deficiency |
| Chronic Granulomatous Disease (CGD) |
| Combined immunodeficiency due to magnesium deficiency (XMEN) |
| Common Variable Immunodeficiency – type 1 |
| Common Variable Immunodeficiency – type 2 |
| Common Variable Immunodeficiency – type 8 |
| Crohn’s disease |
| Defect in Thyroid Hormonogenesis |
| Dermatomyositis |
| Factor V Leiden Mutation |
| Familial hemophagocytic lymphohistiocytosis (HLH) |
| Graves’ Disease |
| Guillain-Barré Syndrome |
| HLA-DQ2.2 |
| HLA-DQ2.5 |
| HLA-DQ4 |
| HLA-DQ7 |
| HLA-DQ8 |
| Herpes |
| Immunodeficiency with Hyper IgM – type 1 |
| Increased Susceptibility to Contracting HIV-1 |
| Lichen Planus |
| Lupus |
| Lupus anticoagulant |
| Lymphedema |
| MYD88 deficiency |
| Mannose Binding Protein Deficiency |
| Mutation of the SERPINE1 Gene (PAI-1) |
| Myeloperoxidase Deficiency |
| Neurosarcoidosis |
| Polyglandular deficiency syndromes |
| Primary Sclerosing Cholangitis |
| Prolactin Promoter Polymorphism |
| Protein C Deficiency |
| Protein S Deficiency |
| Psoriasis |
| Psoriatic arthritis |
| Risk of Decreased Metabolism of Thyroid Hormones |
| Severe Combined Immunodeficiency Syndrome |
| Severe Combined Immunodeficiency with Sensitivity to Ionizing Radiation |
| Severe Congenital Neutropenia |
| Severe Congenital Neutropenia and Cyclic Neutropenia |
| T Lymphocyte Deficiency |
| Type 2 X-linked Lymphoproliferative Syndrome |
| Wegener’s granulomatosis |
| X-Linkerd Lymphoproliferative (XLP) Syndrome |
| X-linked Lymphoproliferative Syndrome (XLP) |